ArticleCancers2021

Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study.

Ifigenia Vasiliadou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.